Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1025366.RA2R2zoqxVanTGSu_FXzc7gGy0Z8lF8d4XCtVnZB2_JOQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1025366.RA2R2zoqxVanTGSu_FXzc7gGy0Z8lF8d4XCtVnZB2_JOQ130_assertion type Assertion NP1025366.RA2R2zoqxVanTGSu_FXzc7gGy0Z8lF8d4XCtVnZB2_JOQ130_head.
- NP1025366.RA2R2zoqxVanTGSu_FXzc7gGy0Z8lF8d4XCtVnZB2_JOQ130_assertion description "[In total, 82 patients with CML who had been administered 400 mg IM daily for over 6 months were genotyped for 11 single-nucleotide polymorphisms in nine genes (CYP3A4, CYP3A5, CYP2C9, CYP2C19, CYP2D6, ABCB1, SLC22A1, SLC22A2 and ABCG2) using blood samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1025366.RA2R2zoqxVanTGSu_FXzc7gGy0Z8lF8d4XCtVnZB2_JOQ130_provenance.
- NP1025366.RA2R2zoqxVanTGSu_FXzc7gGy0Z8lF8d4XCtVnZB2_JOQ130_assertion evidence source_evidence_literature NP1025366.RA2R2zoqxVanTGSu_FXzc7gGy0Z8lF8d4XCtVnZB2_JOQ130_provenance.
- NP1025366.RA2R2zoqxVanTGSu_FXzc7gGy0Z8lF8d4XCtVnZB2_JOQ130_assertion SIO_000772 23117072 NP1025366.RA2R2zoqxVanTGSu_FXzc7gGy0Z8lF8d4XCtVnZB2_JOQ130_provenance.
- NP1025366.RA2R2zoqxVanTGSu_FXzc7gGy0Z8lF8d4XCtVnZB2_JOQ130_assertion wasDerivedFrom befree-2016 NP1025366.RA2R2zoqxVanTGSu_FXzc7gGy0Z8lF8d4XCtVnZB2_JOQ130_provenance.
- NP1025366.RA2R2zoqxVanTGSu_FXzc7gGy0Z8lF8d4XCtVnZB2_JOQ130_assertion wasGeneratedBy ECO_0000203 NP1025366.RA2R2zoqxVanTGSu_FXzc7gGy0Z8lF8d4XCtVnZB2_JOQ130_provenance.